Catherine Schulte
Stock Analyst at Baird
(4.23)
# 473
Out of 5,033 analysts
139
Total ratings
60.68%
Success rate
11.74%
Average return
Main Sectors:
Stocks Rated by Catherine Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Outperform | $141 → $142 | $143.00 | -0.70% | 17 | Aug 28, 2025 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,210 → $1,230 | $1,357.26 | -9.38% | 10 | Aug 4, 2025 | |
| AVTR Avantor | Maintains: Outperform | $18 → $15 | $15.18 | -1.19% | 13 | Aug 4, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $553 → $567 | $543.84 | +4.26% | 28 | Jul 24, 2025 | |
| DHR Danaher | Maintains: Outperform | $226 → $229 | $208.39 | +9.89% | 11 | Jul 23, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $3 → $2 | $3.52 | -43.18% | 6 | May 13, 2025 | |
| EXAS Exact Sciences | Maintains: Outperform | $69 → $72 | $62.73 | +14.78% | 14 | May 2, 2025 | |
| QGEN Qiagen | Maintains: Neutral | $42 → $43 | $48.67 | -11.65% | 4 | Apr 21, 2025 | |
| TECH Bio-Techne | Downgrades: Neutral | $88 → $68 | $62.54 | +8.73% | 11 | Feb 19, 2025 | |
| CSTL Castle Biosciences | Maintains: Outperform | $42 → $38 | $23.01 | +65.15% | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $56 → $33 | $32.74 | +0.79% | 3 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $335 → $281 | $99.50 | +182.41% | 7 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $208 → $217 | $343.18 | -36.77% | 7 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $188.60 | -89.40% | 1 | Jun 28, 2018 |
Agilent Technologies
Aug 28, 2025
Maintains: Outperform
Price Target: $141 → $142
Current: $143.00
Upside: -0.70%
Mettler-Toledo International
Aug 4, 2025
Maintains: Neutral
Price Target: $1,210 → $1,230
Current: $1,357.26
Upside: -9.38%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $18 → $15
Current: $15.18
Upside: -1.19%
Thermo Fisher Scientific
Jul 24, 2025
Maintains: Outperform
Price Target: $553 → $567
Current: $543.84
Upside: +4.26%
Danaher
Jul 23, 2025
Maintains: Outperform
Price Target: $226 → $229
Current: $208.39
Upside: +9.89%
Maravai LifeSciences Holdings
May 13, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $3.52
Upside: -43.18%
Exact Sciences
May 2, 2025
Maintains: Outperform
Price Target: $69 → $72
Current: $62.73
Upside: +14.78%
Qiagen
Apr 21, 2025
Maintains: Neutral
Price Target: $42 → $43
Current: $48.67
Upside: -11.65%
Bio-Techne
Feb 19, 2025
Downgrades: Neutral
Price Target: $88 → $68
Current: $62.54
Upside: +8.73%
Castle Biosciences
Mar 1, 2023
Maintains: Outperform
Price Target: $42 → $38
Current: $23.01
Upside: +65.15%
Nov 21, 2022
Maintains: Outperform
Price Target: $56 → $33
Current: $32.74
Upside: +0.79%
Sep 22, 2020
Maintains: Neutral
Price Target: $335 → $281
Current: $99.50
Upside: +182.41%
Oct 30, 2019
Maintains: Neutral
Price Target: $208 → $217
Current: $343.18
Upside: -36.77%
Jun 28, 2018
Maintains: Outperform
Price Target: $17 → $20
Current: $188.60
Upside: -89.40%